167 related articles for article (PubMed ID: 32002976)
1. Association of Paraoxonse1 (PON1) Genotypes with the Activity of PON1 in Patients with Parkinson's Disease.
Mota A; Hemati-Dinarvand M; Akbar Taheraghdam A; Reza Nejabati H; Ahmadi R; Ghasemnejad T; Hasanpour M; Valilo M
Acta Neurol Taiwan; 2019 Sep; 28(3)():66-74. PubMed ID: 32002976
[TBL] [Abstract][Full Text] [Related]
2. Do PON1-Q192R and PON1-L55M polymorphisms modify the effects of hypoxic training on paraoxonase and arylesterase activity?
Yigittürk O; Turgay F; Kızıldağ S; Özsoylu D; Balcı GA
J Sport Health Sci; 2023 Mar; 12(2):266-274. PubMed ID: 33188964
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.
Nawaka N; Pansang P; Saniwa A; Chaibut N; Jeenduang N
Int J Clin Pract; 2021 Dec; 75(12):e14982. PubMed ID: 34637171
[TBL] [Abstract][Full Text] [Related]
4. Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.
Ahmed NS; Shafik NM; Elraheem OA; Abou-Elnoeman SE
Asian Pac J Cancer Prev; 2015; 16(2):803-9. PubMed ID: 25684529
[TBL] [Abstract][Full Text] [Related]
5. Role of PON1 L55M Gene Polymorphism in Parkinson's Disease among North Indian Population.
Kumar B; Saluja A; Juneja A; Anand KS; Saraswathy KN; Longkumer I; Dhamija RK
Neurol India; 2024 Mar; 72(2):364-367. PubMed ID: 38691483
[TBL] [Abstract][Full Text] [Related]
6. The association of paraoxonase I gene polymorphisms Q192R (rs662) and L55M (rs854560) and its activity with metabolic syndrome components in fars ethnic group.
Marjani A; Poursharifi N; Hashemi MM; Sajedi A; Tatari M
Horm Mol Biol Clin Investig; 2023 Sep; 44(3):295-303. PubMed ID: 36793191
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
Kirbas A; Kirbas S; Cure MC; Tufekci A
J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
[TBL] [Abstract][Full Text] [Related]
9. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
10. Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.
Belin AC; Ran C; Anvret A; Paddock S; Westerlund M; Håkansson A; Nissbrandt H; Söderkvist P; Dizdar N; Ahmadi A; Anvret M; Willows T; Sydow O; Galter D
Neurosci Lett; 2012 Jul; 522(1):30-5. PubMed ID: 22704918
[TBL] [Abstract][Full Text] [Related]
11. Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans.
Taravati A; Ardestani SK; Ziaee AA; Ghorbani A; Soroush MR; Faghihzadeh S; Kazemi H; Rezaei A; Hoseini H; Ghazanfari T
Int Immunopharmacol; 2013 Nov; 17(3):974-9. PubMed ID: 23370296
[TBL] [Abstract][Full Text] [Related]
12. Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease.
Carmine A; Buervenich S; Sydow O; Anvret M; Olson L
Mov Disord; 2002 Jul; 17(4):764-6. PubMed ID: 12210872
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
[TBL] [Abstract][Full Text] [Related]
14. Relationship Between Paraoxonase-1 and Butyrylcholinesterase Activities and Nutritional Status in Mexican Children.
Ramírez-Jiménez R; Martínez-Salazar MF; Almenares-López D; Yáñez-Estrada L; Monroy-Noyola A
Metab Syndr Relat Disord; 2018 Mar; 16(2):90-96. PubMed ID: 29393817
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase-1 55/192 genotypes in schizophrenic patients and their relatives in Turkish population.
Kucukali CI; Aydin M; Ozkok E; Orhan N; Cakir U; Kilic G; Ozbek Z; Ince N; Kara I
Psychiatr Genet; 2008 Dec; 18(6):289-94. PubMed ID: 19018234
[TBL] [Abstract][Full Text] [Related]
16. Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.
Bounafaa A; Berrougui H; Ghalim N; Nasser B; Bagri A; Moujahid A; Ikhlef S; Camponova P; Yamoul N; Simo OK; Essamadi A; Khalil A
PLoS One; 2015; 10(8):e0133719. PubMed ID: 26241956
[TBL] [Abstract][Full Text] [Related]
17. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S
Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
[TBL] [Abstract][Full Text] [Related]
18. Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies.
Bae SS; Shahbazian A; Wang J; Golub I; Oganesian B; Dowd T; Vayngortin B; Wang R; Elashoff D; Reddy ST; Charles-Schoeman C
Rheumatology (Oxford); 2022 May; 61(6):2512-2523. PubMed ID: 34698804
[TBL] [Abstract][Full Text] [Related]
19. Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis.
Bae SC; Lee YH
Clin Rheumatol; 2019 Aug; 38(8):2141-2149. PubMed ID: 30868319
[TBL] [Abstract][Full Text] [Related]
20. Pesticides exposure and genetic polymorphism of paraoxonase in the susceptibility of Parkinson's disease.
Fong CS; Cheng CW; Wu RM
Acta Neurol Taiwan; 2005 Jun; 14(2):55-60. PubMed ID: 16008163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
